MAAT PHARMA | WebDisclosure

Basculer en Français

10813	Companies
234250	Keywords
163043	Articles
125262	Press releases

Home
Companies
MAAT PHARMA

PRESS RELEASE

published on 11/19/2025 at 11:11, 8 months 20 days ago

Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for MaaT Pharma SACA, citing successful €9.1m capital raise with strong investor support for lead drug Xervyteg. Company well-positioned for commercialization

First Berlin Equity Research Capital Increase Investment Advice Xervyteg MaaT Pharma SACA
PRESS RELEASE

published on 11/19/2025 at 08:41, 8 months 20 days ago

Rapport Financier Semestriel 2025
PRESS RELEASE

published on 11/18/2025 at 12:52, 8 months 21 days ago

Rapport Financier Semestriel 2025
PRESS RELEASE

published on 11/18/2025 at 12:48, 8 months 21 days ago

Rapport Semestriel 2025
BRIEF

published on 11/14/2025 at 23:10, 8 months 24 days ago

MaaT Pharma: successful fundraising of 9.1 million euros

Investors Biotechnology Fundraising Microbiome Medical Innovation
BRIEF

published on 11/14/2025 at 23:10, 8 months 24 days ago

MaaT Pharma : levée de fonds réussie de 9,1 millions d'euros

Biotechnologie Innovation Médicale Investisseurs Microbiome Levée De Fonds
PRESS RELEASE

published on 11/14/2025 at 23:05, 8 months 24 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
MaaT Pharma annonce le succès de son Offre Globale de 9,1 millions d'euros pour le développement de Microbiome Ecosystem Therapies™. Levée de fonds pour Xervyteg® et MaaT033

Microbiome Ecosystem Therapies Offre Globale MaaT Pharma MaaT033 Xervyteg
PRESS RELEASE

published on 11/14/2025 at 23:05, 8 months 24 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
MaaT Pharma successfully completes Global Offering of €9.1 million, strengthening financial position and supporting development of Microbiome Therapies for cancer patients

Financial Position Global Offering MaaT Pharma Cancer Patients Microbiome Therapies
BRIEF

published on 11/13/2025 at 19:45, 8 months 25 days ago

Lancement d'une augmentation de capital par MaaT Pharma

Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
BRIEF

published on 11/13/2025 at 19:45, 8 months 25 days ago

MaaT Pharma launches a capital increase

Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing

Accesswire

Published on 08/08/2026 at 00:00, 1 day 16 hours ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 1 day 17 hours ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 17 hours ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 17 hours ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 18 hours ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/09/2026 at 15:05, 1 hour 18 minutes ago

GearUP and Escape from Tarkov Partner to Enhance Online Gaming Experience for the New Season
Published on 08/09/2026 at 00:01, 16 hours 22 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 23 hours 58 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 17 hours ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 20 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 08/07/2026 at 18:54, 1 day 21 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 21 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 21 hours ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 21 hours ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 22 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE